| Univariate |
P-value |
OR |
95% CI |
| Age (per year) |
<0.001 |
1.117 |
1.050 – 1.188 |
| Gender male |
0.287 |
0.548 |
0.182 – 1.657 |
| BMI |
0.287 |
0.916 |
0.778 – 1.077 |
| Current smoker |
0.055 |
0.285 |
0.079 – 1.030 |
| Diabetes |
0.208 |
2.302 |
0.629 – 8.419 |
| Hypertension |
0.206 |
1.981 |
0.687– 5.707 |
| Hypercholesterolaemia |
0.686 |
0.767 |
0.212 – 2.777 |
| Killip Class >1 |
0.045 |
3.341 |
1.025– 10.895 |
| Previous MI |
0.878 |
0.852 |
0.110 – 6.619 |
| Systolic BP (per 10 mm Hg) |
0.702 |
1.044 |
0.839 – 1.298 |
| Diastolic BP (per 10 mm Hg) |
0.317 |
0.827 |
0.570 – 1.199 |
| Tirofiban study medication |
0.324 |
0.575 |
0.191 – 1.730 |
| Culprit Vessel RCA* |
0.756 |
1.401 |
0.166 – 11.792 |
| Culprit Vessel LAD* |
0.558 |
1.877 |
0.228 – 15.465 |
| TIMI grade flow post PCI <3 |
0.013 |
4.476 |
1.365 – 14.682 |
| NT-proBNP baseline (per 1000 increase) |
0.002 |
1.186 |
1.063 – 1.324 |
| NT-proBNP 24 hr (per 1000 increase) |
<0.001 |
1.220 |
1.112 – 1.340 |
| HScTnT (per 0.1 increase) |
0.001 |
1.027 |
1.011 – 1.043 |
| Peak CK-MB (per 100 increase) |
0.047 |
1.213 |
1.003 – 1.467 |
